FDA Orange Book
Generic for Desferal
Desferal contains deferoxamine. Orange Book status for every listed strength, the approved generic makers, and the listed patents and exclusivities.
Source: FDA Orange Book data file dated 2026-10-09. Publisher page
Yes. The generic name for Desferal is deferoxamine. 3 companies hold an active FDA approval (ANDA) for a generic version in the Orange Book. Therapeutic equivalence codes: AP.
Run it in Rivvi
Map Desferal and your other top fills to their generics
Every strength in RxNorm, with brands that have no generic flagged.
Build the mapFree to start. Opens Rivvi, the AI workspace for healthcare teams.
Desferal products in the Orange Book
| Form and route | Strength | Brand status | Brand TE | Active generics | Generic TE codes |
|---|---|---|---|---|---|
| injectable, injection | 2GM/VIAL | Discontinued | None | 3 | AP |
| injectable, injection | 500MG/VIAL | Marketed (Rx) | AP | 3 | AP |
NDA 016267, held by MITEM PHARMA INC. Active generics are ANDA products in the Orange Book prescription list with the same ingredient, dosage form, route and strength.
Approved generic deferoxamine
| Company | ANDA | TE code | Approved | Strengths |
|---|---|---|---|---|
| HOSPIRA INC | 076019 | AP (A-rated, therapeutically equivalent) | March 17, 2004 | 2GM/VIAL, 500MG/VIAL |
| FRESENIUS KABI USA LLC | 078718 | AP (A-rated, therapeutically equivalent) | September 15, 2009 | 2GM/VIAL, 500MG/VIAL |
| GLAND PHARMA LTD | 207384 | AP (A-rated, therapeutically equivalent) | September 29, 2017 | 2GM/VIAL, 500MG/VIAL |
Desferal NDC codes
Questions
Is there a generic for Desferal?
Yes. The generic name for Desferal is deferoxamine. 3 companies hold an active FDA approval (ANDA) for a generic version in the Orange Book. Therapeutic equivalence codes: AP.
What is the generic name for Desferal?
The active ingredient in Desferal is deferoxamine, per the FDA Orange Book.
What does a therapeutic equivalence code mean?
In the Orange Book, codes that start with A (such as AB) mean FDA considers the product therapeutically equivalent to the reference drug. Codes that start with B mean FDA does not, at this time, consider the product therapeutically equivalent.